Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
36 participants
INTERVENTIONAL
2018-11-05
2018-12-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Degree of Digestibility of Barley Rice Proteins
NCT05426122
Effect of Plant Based High Energy High Protein Oral Nutritional Supplement on Nutritional Intake in Patients With or at Risk of Disease Related Malnutrition.
NCT06781619
Bioavailability of Pea Protein in Young and Old Volunteers
NCT06381869
Protein Digestibility in Older and Younger Adults
NCT05534464
Proteins From Duckweed Trial
NCT03823222
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Study population: healthy study subjects, between 35-70y, BMI 18 - 30kg/m2, both males and females.
Intervention (if applicable): Three intervention arms of one week; a bovine plasma protein intervention, a corn protein intervention and a whey protein comparator intervention. Study subjects will receive 40 grams of protein per day during the intervention in two 20 g doses.
Main study parameters/endpoints: The main study parameter is to assess the protein digestion kinetics and protection of the epithelial barrier. Secondary study parameters include other markers of gastrointestinal health, metabolic health, vascular health and satiating properties.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Corn protein
Corn protein powder
Corn protein powder
40g/d ( 2 times 20 grams per day for a period of 1 week)
Bovine plasma protein
Bovine plasma protein powder
Bovine plasma protein powder
40g/d ( 2 times 20 grams per day for a period of 1 week)
control benchmark protein Whey
Whey protein powder
Whey protein powder
40g/d ( 2 times 20 grams per day for a period of 1 week)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Corn protein powder
40g/d ( 2 times 20 grams per day for a period of 1 week)
Bovine plasma protein powder
40g/d ( 2 times 20 grams per day for a period of 1 week)
Whey protein powder
40g/d ( 2 times 20 grams per day for a period of 1 week)
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age between 35-70 y
* BMI between 18 - 30 kg/m2
Exclusion Criteria
* Having a history of medical or surgical events that may significantly affect the study outcome
* Kidney dysfunction (self-reported)
* Gastrointestinal disorders, constipation (defecation \<3 times a week) or history of gastrointestinal surgery
* Allergies for our intervention products
* Recent use of antibiotics (\<1 month prior to day 01 of the study)
* Not having a general practitioner
* Mental status that is incompatible with the proper conduct of the study
* Pregnancy or lactating
* Reported weight loss or weight gain of \> 5 kg in the month prior to pre-study screening
* Reported slimming, medically prescribed, other (extreme) diet, or use of protein concentrates
* Not willing to give up blood donation during the study
* Current smokers
* Alcohol intake \> 3 glasses per day
* Hard-drug abuse
* Participation in other clinical trials in the past month
* Being an employee or student of the department Consumer Science \& Health group of Wageningen Food \& Biobased Research
35 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wageningen University and Research
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Diederik Esser
project leader clinical trials
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Diederik Esser, Dr
Role: PRINCIPAL_INVESTIGATOR
Wageningen research
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Stichting Wageningen Research
Wageningen, Gelderland, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NL65835.081.18
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.